Back
New product information website
Published at: Thursday, 01. March 2007
MEDA Pharma, headquartered in Solna, Sweden, has established a new informational website for patients concerning allergy therapy with the active ingredient Azelastin (i.e. in Allergodil® akut).
Patients can acquire useful information about allergies -the symptoms, the different options of treatment and helpful information about Azelastin - a wide variety of interesting and helpful information is offered at www.azelastine.info.
Currently the information portal is accessible in English and German with four further language versions ( French, Spanish, Italian and Swedish) to be coming soon.
Up-to-date press releases, links to websites from various organisations, associations, and patient groups round off the website. Members of the academic press can access a password-protected site with current press releases.
Azelastin Website:
http://www.azelastine.info
Meda is one of Europe's leading specialty pharma companies, with focus on marketing and market-adapted product development. Long-term partnerships and acquisitions are fundamental factors in its strategy. Meda is represented in 24 countries and has 900 employees in marketing and sales.
